UK Markets closed

23andMe Holding Co. (ME)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.5000-0.1500 (-3.23%)
At close: 04:00PM EST
4.3000 -0.20 (-4.44%)
After hours: 07:59PM EST
Sign in to post a message.
  • g
    gene
    Let’s see $15 again
  • J
    JB
    long-term winner. buy a little monthly. Not many companies get paid to take your data. They will be paid much more for that dataset.
  • K
    Karen
    This is unacceptable! If we don’t get back to $6 by the end of this week, I’m calling corporate and demanding to speak with the manager!!
  • R
    R
    They are starting a trial for their in house drug 23ME-00610 ---a monoclonal antibody treatment for solid tumors-----"23ME-00610 is a monoclonal antibody therapy designed to prevent an immune interaction that stops immune cells from doing their job, what’s known as a checkpoint inhibitor. Similar drugs that are already on the market include Merck & Co.’s blockbuster cancer drug Keytruda and Bristol Myers Squibb Co.’s Opdivo"--- these in-house drugs of which there may be 40 in-house drugs--- that plus the GSK colab--- plus the test kits--- plus the DNA database ----plus Lemonaid Health--- they are really making all the smart moves and firing on every possible angle-----so IMO the future here is very bright and on any solid real positive news this will be unstoppable
  • j
    j
    This technology is the future.
  • H
    Hari
    I heard the presentation. Only one analyst from Citi Bank was attending & he asked a few questions. Let us see if he update or not.

    I have a very small position in the stock. I don't expect anything happening soon after seeing the presentation. Lot in the pipeline but all untested.
  • D
    DH
    GSK extended the collaboration for another year and paid $50 million to ME.
    Just need a good analyst to upgrade ME.
  • h
    hbgamer
    added more. In few months might look into buying a bunch of other beaten down tech stocks
  • C
    Cindy
    Bought 5000 shares yesterday. New to this board. Good buy in anyones opinion?
  • D
    DH
    There are 13 million shares shorted, that’s more than 4 days total volume. There’s no fundamental change since $13/share. I doubt this will stay at this $5 level. Just need one solid upgrade and shorts will scramble to cover.
  • A
    Anton
    The only reason I'm holding tight it's because I see people fear selling.
  • n
    ned
    Hmmm. I am an investor who wants to believe, but scratching my head asking "Is there a fundamental problem?" While the promise is outstanding, there must be an operational risk/issue or market risk/issue that I am not seeing. Any insights would be greatly appreciated. GLTA
  • R
    Robert
    Just took a position in this stock 2 days ago. Already down 10%? Is there any hope here or should I run?
  • K
    Kyle
    when does th bleeding stop? insiders stop selling?
  • h
    hbgamer
    what a gift. Whoever is selling doesn't understand the game. The sellers are acting like the company is going bankrupt.
  • D
    Daniel
    So everything goes up an me goes down 🙃
  • D
    Daniel
    This stock keeps embarrassing me and my decision to hold lol
  • m
    mp
    Just bought some after hours. Genetic testing to fighting cancer with fda approval is huge. People just don't see the positive news that's pouring out right now
  • M
    M
    I'm wondering if the price drop is due to the previous warrant holders (mainly hedge funds and investment firms) dumping the shares that they had to convert in Dec 2021 after the company called in the warrants. If so, then the price drop should subside after the selling is finished and a bottom should form.
  • h
    hbgamer
    With all of the good news coming out for ME you would think this stock should be flying higher